Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$699K Sell
29,042
-620
-2% -$16.2K 0.07% 120
2026
Q1
$833K Hold
29,662
0.1% 107
2025
Q4
$739K Buy
29,662
+300
+1% +$7.57K 0.08% 117
2025
Q3
$748K Sell
29,362
-829
-3% -$20.5K 0.08% 116
2025
Q2
$732K Sell
30,191
-2,838
-9% -$66.2K 0.09% 115
2025
Q1
$837K Sell
33,029
-2,711
-8% -$70.9K 0.11% 105
2024
Q4
$948K Sell
35,740
-8,054
-18% -$218K 0.12% 100
2024
Q3
$1.27M Sell
43,794
-4,860
-10% -$142K 0.16% 86
2024
Q2
$1.36M Sell
48,654
-5,751
-11% -$158K 0.18% 83
2024
Q1
$1.51M Sell
54,405
-15,154
-22% -$421K 0.21% 78
2023
Q4
$2M Sell
69,559
-8,188
-11% -$248K 0.3% 70
2023
Q3
$2.58M Sell
77,747
-6,167
-7% -$218K 0.42% 57
2023
Q2
$3.08M Sell
83,914
-4,732
-5% -$184K 0.49% 51
2023
Q1
$3.62M Sell
88,646
-1,979
-2% -$85.5K 0.62% 48
2022
Q4
$4.64M Sell
90,625
-1,392
-2% -$66.7K 0.85% 38
2022
Q3
$4.03M Sell
92,017
-159
-0.2% -$7.73K 0.79% 39
2022
Q2
$4.83M Sell
92,176
-846
-0.9% -$43.1K 0.91% 33
2022
Q1
$4.82M Sell
93,022
-6,084
-6% -$316K 0.77% 39
2021
Q4
$5.85M Buy
99,106
+1,026
+1% +$50.8K 0.85% 36
2021
Q3
$4.22M Sell
98,080
-4,518
-4% -$200K 0.66% 44
2021
Q2
$4.02M Buy
102,598
+1,415
+1% +$55K 0.63% 48
2021
Q1
$3.67M Buy
101,183
+1,872
+2% +$66.5K 0.62% 49
2020
Q4
$3.66M Buy
99,311
+1,503
+2% +$55.1K 0.65% 46
2020
Q3
$3.41M Buy
97,808
+6,076
+7% +$213K 0.68% 44
2020
Q2
$2.85M Buy
91,732
+3,039
+3% +$103K 0.63% 48
2020
Q1
$2.75M Sell
88,693
-3,120
-3% -$106K 0.74% 42
2019
Q4
$3.41M Sell
91,813
-625
-0.7% -$22.3K 0.72% 45
2019
Q3
$3.15M Sell
92,438
-512
-0.6% -$18.6K 0.73% 46
2019
Q2
$3.82M Sell
92,950
-838
-0.9% -$33.3K 0.88% 37
2019
Q1
$3.78M Buy
93,788
+606
+0.7% +$24.3K 0.92% 33
2018
Q4
$3.86M Buy
93,182
+1,212
+1% +$50.3K 1.08% 28
2018
Q3
$3.85M Buy
91,970
+1,047
+1% +$40.3K 0.9% 35
2018
Q2
$3.13M Sell
90,923
-1,423
-2% -$48.6K 0.8% 44
2018
Q1
$3.11M Sell
92,346
-1,194
-1% -$41K 0.8% 44
2017
Q4
$3.21M Sell
93,540
-143
-0.2% -$4.88K 0.81% 44
2017
Q3
$3.17M Sell
93,683
-2,309
-2% -$74.2K 0.85% 42
2017
Q2
$3.06M Sell
95,992
-1,989
-2% -$62.7K 0.83% 41
2017
Q1
$3.18M Sell
97,981
-1,816
-2% -$57.3K 0.88% 39
2016
Q4
$3.08M Sell
99,797
-1,580
-2% -$48.2K 0.9% 37
2016
Q3
$3.26M Sell
101,377
-770
-0.8% -$25.7K 1% 30
2016
Q2
$3.41M Sell
102,147
-3,140
-3% -$100K 1.04% 29
2016
Q1
$2.96M Buy
105,287
+77
+0.1% +$2.2K 0.94% 33
2015
Q4
$3.22M Sell
105,210
-2,187
-2% -$68.8K 1.02% 31
2015
Q3
$3.2M Buy
107,397
+3,621
+3% +$116K 1.1% 30
2015
Q2
$3.3M Sell
103,776
-552
-0.5% -$18K 1.08% 31
2015
Q1
$3.44M Buy
104,328
+703
+0.7% +$22.4K 1.13% 27
2014
Q4
$3.06M Buy
103,625
+441
+0.4% +$12.6K 1.01% 35
2014
Q3
$2.9M Sell
103,184
-2,625
-2% -$73.7K 0.98% 34
2014
Q2
$2.98M Buy
105,809
+15,152
+17% +$432K 0.99% 34
2014
Q1
$2.76M Buy
90,657
+1,507
+2% +$44.9K 0.98% 34
2013
Q4
$2.59M Sell
89,150
-106
-0.1% -$3.08K 0.9% 38
2013
Q3
$2.43M Buy
89,256
+3,187
+4% +$86.7K 0.93% 36
2013
Q2
$2.29M Buy
+86,069
New +$2.38M 0.94% 32

Other funds holding PFE

J.W. Burns & Co's PFE Position: Q2 2026 in Review

J.W. Burns & Co reduced its Pfizer (PFE) stake by 2.1% in Q2 2026, selling an estimated $16.2K and leaving 29,042 shares worth $699K. The position accounts for 0.07% of the portfolio, ranked #120.

J.W. Burns & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.85M in Q4 2021. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • J.W. Burns & Co held 29,042 shares of Pfizer worth $699K as of Q2 2026.
  • J.W. Burns & Co sold 620 Pfizer shares in Q2 2026, an estimated $16.2K.
  • Pfizer made up 0.07% of J.W. Burns & Co's portfolio in Q2 2026, its #120 holding.
  • J.W. Burns & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • J.W. Burns & Co's Pfizer position peaked at $5.85M in Q4 2021.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on J.W. Burns & Co's 13F filing for Q2 2026, filed 15 Jul 2026.